跳至主要内容
临床试验/CTRI/2023/08/056974
CTRI/2023/08/056974尚未招募Unknown

Evaluation of safety and efficacy of delamanid in patients with multidrug-resistant tuberculosis (MDR-TB) - NA

Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients capable of giving written informed consent
  • 2.Diagnosis of MDR-TB on CBNAAT or sputum culture
  • 3.Chest radiograph diagnostic of TB
  • 4.Positive sputum sample
  • 5.Normal ECG

排除标准

  • 1.Serum albumin: < 2.8g/dL
  • 2.Patient on drug of strong inducer of CYP3A4 enzyme
  • 3.Severe renal impairment
  • 4.Moderate or severe hepatic impairment
  • 5.Hypersensitivity to drug
  • 6.Infection by Mycobacterial species other than those of the mycobacterium complex
  • 7.Abnormal ECG and QTc
  • 9.Body mass index (BMI) < 16 kg/m2
  • 10.Karnofsky score < 50%
  • 11.Significant metabolic, gastrointestinal, neurological, psychiatric, or endocrine diseases, active malignancy
  • 12.History of alcohol abuse
  • 13.Pregnant, breast-feeding or planning to conceive
  • 14.Previous exposure to Delamanid

研究者

发起方
Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh

相似试验